Radioembolization is an established treatment modality that has been subjected to many
improvements over the last decade. Developments are occurring at a high pace, affecting …

90 Y resin radioembolization is an emerging treatment in patients with liver-dominant
metastatic neuroendocrine tumors (mNETs), despite the absence of level I data. The aim of this …

Radioembolization (RE) is a relatively novel treatment modality for primary and secondary
hepatic malignancies. Microspheres embedded with a β-emitting radioisotope are injected …

Radioembolization with yttrium-90 microspheres ( 90 Y-RE), either glass- or resin-based, is
increasingly applied in patients with unresectable liver malignancies. Clinical results are …

In hepatic 90 Y radioembolization, pretreatment 99m Tc-macroaggregated albumin ( 99m Tc-MAA)
nuclear imaging is used for lung shunt analysis, evaluation of extrahepatic deposition…

Background After yttrium-90 ( 90 Y) microsphere radioembolization (RE), evaluation of
extrahepatic activity and liver dosimetry is typically performed on 90 Y Bremsstrahlung SPECT …

Background The efficacy of radioembolisation for the treatment of liver tumours depends on
the selective distribution of radioactive microspheres to tumorous tissue. The distribution of …

Background: 18 F-Fluorodeoxyglucose (FDG) positron-emission tomography/computed
tomography (PET/CT) was recently introduced as a new tool for the diagnosis of prosthetic heart …

Adequate suppression of cardiac glucose metabolism increases the interpretability and
diagnostic reliability of 18 F-FDG PET studies performed to detect cardiac inflammation and …

Purpose Radiation pneumonitis is a rare but serious complication of radioembolic therapy
of liver tumours. Estimation of the mean absorbed dose to the lungs based on pretreatment …